| Literature DB >> 27386374 |
Sonia Mahey1, Rakesh Kumar2, Rohit Arora1, Jyoti Mahajan1, Saroj Arora1, Renu Bhardwaj1, Ashwani Kumar Thukral1.
Abstract
The present study investigates the anti-proliferative and apoptosis inducing mechanism of CoCl2·6H2O in PC-3 cancer cell line. Preliminary, three different forms of cobalt i.e., cobaltous (CoCl2·6H2O), macro-Co(II,III) oxide and nano-Co(II,III) oxide were screened for antiproliferative activity in PC-3 cell line. The CoCl2·6H2O being the most effective antiproliferative agent, hence it was further tested against lung (A549), prostrate (PC-3) and brain (IMR-32) cell lines. Human embryonic kidney cell line (293T) was used as a normal cell line to compare the toxicity of CoCl2·6H2O. The CoCl2·6H2O induced morphological and anatomical changes in PC-3 cancer cell which were studied using light, confocal and scanning electron microscopy. The lactate dehydrogenase was estimated which showed mild necrotic mode of cell death. The Annexin/PI staining confirmed the apoptotic mode of cell death in PC-3 cells. Further, production of reaction of reactive oxygen species and changes in mitochondrial membrane potential was also assessed spectrofluorimetrically. The cell cycle arrest was also investigated using flow cytometery. Finally, the caspase activity was estimated in CoCl2·6H2O treated PC-3 cancer cell line. Interestingly, it was found that CoCl2·6H2O induces more cell death in cancerous cells as compared to normal non-cancerous cells. These findings presented CoCl2·6H2O as potential antiproliferative agent.Entities:
Keywords: Antiproliferative; Apoptosis; CoCl2·6H2O; MTT
Year: 2016 PMID: 27386374 PMCID: PMC4929113 DOI: 10.1186/s40064-016-2405-0
Source DB: PubMed Journal: Springerplus ISSN: 2193-1801
Percent inhibition of prostrate (PC-3) cancer cell lines treated with different concentration of CoCl2·6H2O, Macro-Co(II,III) oxide and Nano-Co(II,III) oxide
| Conc. (mg/L) | CoCl2·6H2O | Macro-Co(II,III) oxide | Nano-Co(II,III) oxide |
|---|---|---|---|
| % Inhibition | |||
| 10 | 33.13 | 3.94 | −12.31 |
| 25 | 46.86 | 5.95 | −4.47 |
| 50 | 61.45 | 8.81 | 6.29 |
| 75 | 71.12 | 10.56 | 9.93 |
| 100 | 79.56 | 13.70 | 14.12 |
Percent inhibition, IC50 values of various cell lines treated with different concentrations of CoCl2·6H2O (5–100 mg/L) by using best fit regression model
| Concentration of CoCl2·6H2O (mg/L) (x) | ||||||||
|---|---|---|---|---|---|---|---|---|
| Cell line | Inhibition (%) (y) | Regression equation | IC50 | |||||
| 5 | 10 | 25 | 50 | 75 | 100 | |||
| 293 T | 7.27 | 16.97 | 27.73 | 47.26 | 62.67 | 69.72 | y = 20.92 ln(x) − 31.03 | 48.1 |
| IMR-32 | 31.24 | 66.60 | 77.22 | 78.10 | 79.01 | 79.22 | y = 13.59 ln(x) + 23.33 | 7.12 |
| PC-3 | 19.80 | 31.58 | 49.70 | 67.98 | 80.36 | 82.08 | y = 21.86 ln(x) − 17.49 | 21.91 |
| A549 | 0.817 | 5.48 | 46.92 | 73.61 | 80.02 | 80.79 | y = 30.61 ln(x) − 53.93 | 29.81 |
R *** P < 0.001; *** P < 0.001; n = 5
Fig. 1Subculturing of dead 293T and PC-3 cells after treatment with CoCl2·6H2O after 24 h. a 293T cells without treatment, b 293T cells with CoCl2·6H2O (IC50) treatment, c PC-3 cells without treatment, d PC-3 cells with CoCl2·6H2O (IC50) treatment
Fig. 2Phase contrast micrographs (40X, Nikon eclipse TS100) of CoCl2·6H2O concentrations effect (5–100 mg/L) on morphology of PC-3 cells observed after 12–14 h of treatment at magnification of ×40
Fig. 3Confocal micrographs (Nikon eclipse TiE inverted fluorescence microscope, Nikon Corp. Japan) of effect of CoCl2·6H2O treatment (IC50 and IC70, 12–14 h treatment) on morphology of PC-3 cells
Fig. 4Scanning electron micrographs (EVO LS 10. Carl Zeiss Germany) of effect of CoCl2·6H2O (IC50, 12–14 h treatment) on morphology of PC-3 cells
Fig. 5Cell cycle analysis in PC-3 cells of untreated control, positive control (campthothecin), IC50 and IC70 treatment of CoCl2·6H2O. Cells were stained with PI (5 µg/mL for 20 min) and analysed using BD Accuri C6 flow cytometer
Change in LDH, ROS, MMP and caspase activities at IC50 and IC70 concentrations of CoCl2·6H2O for 12–14 h treatment in PC-3 cancer cell line with respect to untreated PC-3 cells
| LDH | ROS | MMP | Caspase | |
|---|---|---|---|---|
| Untreated PC-3 cells | 100 | 100 | 100 | 100 |
| Camptothecin (10 µM) treated PC-3 cells | 126.7 | 176.5 | 72.7 | 174.1 |
| CoCl2·6H2O (IC50) treated PC-3 cells | 123.2 | 152.9 | 80 | 170.4 |
| CoCl2·6H2O (IC70) treated PC-3 cells | 138.2 | 211.8 | 73.3 | 177.8 |
| χ2 | 27.07*** | 211.42*** | 18.55*** | 164.88*** |
IC50 and IC70 doses calculated using regression equation: y = 21.86 ln(x) − 17.49
*** P < 0.001; n = 3
Fig. 6Annexin V/propidium iodide staining for confirmation of apoptosis and necrosis in PC-3 cells with IC50 and IC70 treatments of CoCl2·6H2O in comparison to control and camptothecin (10 µM) as positive standard